Clinical Trials Browser

Phase 2 × Hereditary Breast and Ovarian Cancer Syndrome × Tamoxifen × Clear all

NCT00253539 2011-04-13

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome